Drug Type Oligonucleotide |
Synonyms- |
Target |
Action inhibitors |
Mechanism 17β-HSD13 inhibitors(17-beta-hydroxysteroid dehydrogenase 13 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cardiovascular Diseases | Discovery | - | 24 Jul 2025 | |
| Chronic nephritis | Discovery | - | 24 Jul 2025 | |
| Diabetes Mellitus, Type 2 | Discovery | - | 24 Jul 2025 | |
| Digestive System Disorders | Discovery | - | 24 Jul 2025 |





